[HTML][HTML] Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
[PDF][PDF] Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
scholar.archive.org
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
[PDF][PDF] Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
P Gauckler, J Il Shin, F Alberici, V Audard, A Bruchfeld… - 2020 - repository.ubn.ru.nl
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
RITERM study group - Autoimmunity Reviews, 2020 - mayoclinic.elsevierpure.com
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
P Gauckler, G Mayer, A Kronbichler, JI Shin… - Autoimmunity …, 2020 - elibrary.ru
VA reports grants from ADDMEDICA, outside the submitted work; AB reports consulting fees
from Chemocentryx, from Merck/MSD and from Astra Zeneca, outside the submitted work; …
from Chemocentryx, from Merck/MSD and from Astra Zeneca, outside the submitted work; …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
P Gauckler, JI Shin, F Alberici, V Audard… - Autoimmunity …, 2020 - discovery.ucl.ac.uk
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
P Gauckler, JI Shin, F Alberici, V Audard… - Autoimmunity …, 2020 - portal.research.lu.se
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
RITERM study group - Autoimmunity Reviews, 2020 - yonsei.elsevierpure.com
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
P Gauckler, J Il Shin, F Alberici, V Audard… - Autoimmunity …, 2020 - diva-portal.org
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown?
P Gauckler, JI Shin, F Alberici, V Audard… - Autoimmunity …, 2020 - lup.lub.lu.se
Primary forms of minimal change disease and focal segmental glomerulosclerosis are rare
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …
podocytopathies and clinically characterized by nephrotic syndrome. Glucocorticoids are the …